Total Payments
$6,474
2024 Payments
$49.99
Companies
39
Transactions
438
Medicare Patients
2,340
Medicare Billing
$231,139
Payment Breakdown by Category
Food & Beverage$6,474 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,474 | 438 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $895.30 | 84 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $810.06 | 49 | $0 (2024) |
| Amgen Inc. | $699.46 | 34 | $0 (2023) |
| ABBVIE INC. | $697.96 | 51 | $0 (2023) |
| Lilly USA, LLC | $683.07 | 43 | $0 (2023) |
| GlaxoSmithKline, LLC. | $524.45 | 43 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $300.04 | 20 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $180.47 | 11 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $129.34 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $115.89 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.99 | 1 | AstraZeneca Pharmaceuticals LP ($49.99) |
| 2023 | $1,476 | 84 | AstraZeneca Pharmaceuticals LP ($189.75) |
| 2022 | $1,596 | 94 | AstraZeneca Pharmaceuticals LP ($272.69) |
| 2021 | $1,128 | 76 | AbbVie Inc. ($261.96) |
| 2020 | $349.30 | 30 | Novo Nordisk Inc ($118.29) |
| 2019 | $601.58 | 50 | Novo Nordisk Inc ($111.37) |
| 2018 | $767.28 | 62 | Novo Nordisk Inc ($282.06) |
| 2017 | $505.31 | 41 | Novo Nordisk Inc ($113.12) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: Rare Disease | ||||||
| 12/21/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: UROLOGY | ||||||
| 12/01/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Genetic Disease | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diabetes | ||||||
| 10/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Oncology | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardio-renal | ||||||
| 10/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.15 | General |
| 10/10/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ANTIBIOTIC | ||||||
| 10/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/29/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 383 | 570 | $123,774 | $41,778 |
| 2022 | 8 | 563 | 835 | $179,794 | $64,524 |
| 2021 | 11 | 708 | 977 | $177,279 | $65,765 |
| 2020 | 11 | 686 | 903 | $170,769 | $59,072 |
Total Patients
2,340
Total Services
3,285
Medicare Billing
$231,139
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 362 | $74,572 | $24,090 | 32.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 42 | 42 | $18,396 | $6,452 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $16,416 | $5,765 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 50 | $6,950 | $2,605 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $5,004 | $2,015 | 40.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 36 | 36 | $1,764 | $612.72 | 34.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 14 | 14 | $672.00 | $238.28 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 484 | $99,704 | $34,848 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 162 | 162 | $52,114 | $19,733 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 41 | $11,398 | $4,089 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 59 | $8,201 | $2,928 | 35.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $2,445 | $1,028 | 42.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 26 | 29 | $3,625 | $989.24 | 27.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $1,003 | $463.59 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 17 | 28 | $1,304 | $445.53 | 34.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 234 | 440 | $90,640 | $34,055 | 37.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 123 | 123 | $36,285 | $15,252 | 42.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 129 | 140 | $17,500 | $4,911 | 28.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 107 | $14,873 | $4,628 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 22 | $6,608 | $2,543 | 38.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,410 | $1,207 | 27.4% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 41 | 69 | $3,036 | $1,142 | 37.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $896.00 | $896.00 | 100.0% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 14 | 14 | $1,820 | $579.32 | 31.8% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 18 | 19 | $836.00 | $314.07 | 37.6% |
About Dr. Stephen Morse, DO
Dr. Stephen Morse, DO is a Emergency Medicine healthcare provider based in Bluffton, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1801234729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Morse, DO has received a total of $6,474 in payments from pharmaceutical and medical device companies, with $49.99 received in 2024. These payments were reported across 438 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($6,474).
As a Medicare-enrolled provider, Morse has provided services to 2,340 Medicare beneficiaries, totaling 3,285 services with total Medicare billing of $231,139. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Bluffton, IN
- Active Since 06/13/2013
- Last Updated 10/18/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1801234729
Products in Payments
- FARXIGA (Drug) $687.12
- Otezla (Drug) $430.83
- VRAYLAR (Drug) $368.82
- JARDIANCE (Drug) $368.56
- TRELEGY ELLIPTA (Drug) $350.33
- Ozempic (Drug) $341.12
- MOUNJARO (Drug) $232.61
- TRULICITY (Drug) $211.74
- XIFAXAN (Drug) $180.47
- Victoza (Drug) $149.68
- UBRELVY (Drug) $138.30
- Aimovig (Biological) $118.94
- Vascepa (Drug) $115.89
- REXULTI (Drug) $111.77
- NUZYRA (Drug) $97.41
- ELIQUIS (Drug) $95.08
- Repatha (Biological) $86.77
- TROKENDI XR (Drug) $83.16
- XARELTO (Drug) $77.98
- ANORO (Drug) $74.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Bluffton
Greg Arnette, Md, MD
Emergency Medicine — Payments: $780.18
Emergency Medicine $780.18
Dr. Muhammad Uppal, Md, MD
Emergency Medicine — Payments: $189.60
Emergency Medicine $189.60
Dr. Atul Gupta, M.d, M.D
Emergency Medicine — Payments: $28.71
Emergency Medicine $28.71
Carroll Fowlkes, Do, DO
Emergency Medicine — Payments: $23.63
Emergency Medicine $23.63
Thomas Tropf, Md, MD
Emergency Medicine
Emergency Medicine
Murray Sullivan, Md, MD
Emergency Medicine
Emergency Medicine